Yoon-Jin Lee

Prof. Yoon-Jin Lee

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Nutrition Research and Practice
Verified
Journal Article
Open access
PDF file
SLSang-Han Lee
Sang-Han Lee
Yoon-Jin LeeYoon-Jin Lee
Yoon-Jin Lee
Lee SH, et al. Nutr Res Pract. 2021 Feb;15(1):12-25. https://doi.org/10.4162/nrp.2021.15.1.12

1 January 2020 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
PDF file
Yoon-Jin LeeYoon-Jin Lee
Yoon-Jin Lee
WKWoo Il Kim
Woo Il Kim
JBJin Ho Bae
Jin Ho Bae
MCMoon Kyun Cho
Moon Kyun Cho
SLSang Han Lee
Sang Han Lee
SCSung Woo Cho
Sung Woo Cho
Lee YJ, et al. Ann Surg Treat Res. 2020 Apr;98(4):159-167. https://doi.org/10.4174/astr.2020.98.4.159

1 November 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
Yoon-Jin LeeYoon-Jin Lee
Yoon-Jin Lee
JOJeong-Eun Oh
Jeong-Eun Oh
SLSang-Han Lee
Sang-Han Lee

21 September 2020 in Archives of Dermatological Research
Verified
Journal Article
Closed access
PDF file
Yoon-Jin LeeYoon-Jin Lee
Yoon-Jin Lee
WKWoo Il Kim
Woo Il Kim
TPTae Heum Park
Tae Heum Park
JBJin Ho Bae
Jin Ho Bae
HNHae Seon Nam
Hae Seon Nam
MCMoon Kyun Cho
Moon Kyun Cho

13 March 2025 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
Yoon-Jin LeeYoon-Jin Lee
Yoon-Jin Lee
CSChul Won Seo
Chul Won Seo
SCShinwon Chae
Shinwon Chae
CLChang Yeol Lee
Chang Yeol Lee
SKSang Soo Kim
Sang Soo Kim
DCDongsic Choi
Dongsic Choi
Most cancer cells adopt a less efficient metabolic process of aerobic glycolysis with high level of glucose uptake followed by lactic acid production, known as the Warburg effect. This phenotypic transition enables cancer cells to achieve increased cellular survival and proliferation in a harsh low-oxygen tumor microenvironment. Also, the resulting acidic microenvironment causes inactivation of the immune system such as T-cell impairment that favors escape by immune surveillance. While lots of studies have revealed that tumor-derived EVs can deliver parental materials to adjacent cells and contribute to oncogenic reprogramming, their functionality in energy metabolism is not well addressed. In this study, we established prostate cancer cells PC-3AcT resistant to cellular death in an acidic culture medium driven by lactic acid. Quantitative proteomics between EVs derived from PC-3 and PC-3AcT cells identified 935 confident EV proteins. According to cellular adaptation to lactic acidosis, we revealed 159 regulated EV proteins related to energy metabolism, cellular shape, and extracellular matrix. These EVs contained a high abundance of glycolytic enzymes. In particular, PC-3AcT EVs were enriched with apolipoproteins including apolipoprotein B-100 (APOB). APOB on PC-3AcT EVs could facilitate their endocytic uptake depending on low density lipoprotein receptor of recipient PC-3 cells, encouraging increases of cellular proliferation and survival in acidic culture media via increased activity and expression of hexokinases and phosphofructokinase. The activation of recipient PC-3 cells can increase glucose consumption and ATP generation, representing an acquired metabolic reprogramming into the Warburg phenotype. Our study first revealed that EVs derived from prostate cancer cells could contribute to energy metabolic reprogramming and that the acquired metabolic phenotypic transition of recipient cells could favor cellular survival in tumor microenvironment.

Verified
Journal Article
Open access
PDF file
Yoon-Jin LeeYoon-Jin Lee
Yoon-Jin Lee
CLChangyeol Lee
Changyeol Lee
DCDongsic Choi
Dongsic Choi
YLYeji Lee
Yeji Lee
SLSang-Han Lee
Sang-Han Lee
Genistein, an isoflavone found in soybeans, exhibits antioxidant, anti-inflammatory, and anticancer properties. This study explored the molecular mechanisms behind genistein’s anticancer effects in prostate cancer DU145 cells. In this study, genistein decreased cell viability, increased annexin V-PE(+) cells, and enhanced the sub-G0/G1 peak by flow cytometric analysis. Increased reactive oxygen species increased mitochondrial depolarization indicating mitochondrial dysfunction and inhibition of ATP formation were also observed in genistein-treated DU145 cells. Genistein upregulated p53 at the mRNA and protein levels and increased caspase-3/7 activity along with the cleavage of Bax, procaspase-3, and PARP. With the increasing genistein concentrations, the percentage of cells in the sub-G0/G1 peak and G2/M phase increased, which was inhibited by treatment with the pan-caspase inhibitor Z-VAD together with 100 μM genistein, which had little toxicity to normal prostate epithelial HPrEC cells. Genistein treatment simultaneously inhibited the activation of STAT3 and other closely related oncogenic kinases such as AKT and ERK and p38 and decreased VEGF expression. Taken together, these results suggest that genistein inhibits the growth of DU145 cells and induces apoptosis by inhibiting STAT3, AKT, ERK, and p38 which provides a molecular basis for the anticancer activity of genistein and suggests its potential as a valuable therapeutic candidate for prostate cancer.